Cachectin and tumour necrosis factor as two sides of the same biological coin - PubMed (original) (raw)

Review

. 1986 Apr;320(6063):584-8.

doi: 10.1038/320584a0.

• PMID: 3010124
• DOI: 10.1038/320584a0

Review

Cachectin and tumour necrosis factor as two sides of the same biological coin

B Beutler et al. Nature. 1986 Apr.

Abstract

In response to invasive stimuli macrophages secrete cachectin, a multipotent protein. Prominent among its biological effects is the ability to induce wasting (cachexia) as well as a lethal state of shock. The identity of cachectin and tumour necrosis factor has led to a new view of its therapeutic potential.

PubMed Disclaimer

Similar articles

• Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.
  Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A. Beutler B, et al. Nature. 1985 Aug 8-14;316(6028):552-4. doi: 10.1038/316552a0. Nature. 1985. PMID: 2993897
• Cachectin: more than a tumor necrosis factor.
  Beutler B, Cerami A. Beutler B, et al. N Engl J Med. 1987 Feb 12;316(7):379-85. doi: 10.1056/NEJM198702123160705. N Engl J Med. 1987. PMID: 3543677 Review. No abstract available.
• Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.
  Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, et al. Mohler KM, et al. Nature. 1994 Jul 21;370(6486):218-20. doi: 10.1038/370218a0. Nature. 1994. PMID: 8028669
• The complex regulation and biology of TNF (cachectin).
  Beutler B. Beutler B. Crit Rev Oncog. 1990;2(1):9-18. Crit Rev Oncog. 1990. PMID: 2091751 Review.

Cited by

• Chemical synthetic approaches to mimic the TRAIL: promising cancer therapeutics.
  Masum AA, Aoki S, Rahman MM, Hisamatsu Y. Masum AA, et al. RSC Med Chem. 2024 Aug 1. doi: 10.1039/d4md00183d. Online ahead of print. RSC Med Chem. 2024. PMID: 39246747 Free PMC article. Review.
• Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation.
  Zaher KA, Alrahimi JS, Basingab FS, Aldahlawi AM. Zaher KA, et al. Biomedicines. 2024 Jul 5;12(7):1497. doi: 10.3390/biomedicines12071497. Biomedicines. 2024. PMID: 39062070 Free PMC article.
• IL-6 promotes tumor growth through immune evasion but is dispensable for cachexia.
  Kwon YY, Hui S. Kwon YY, et al. EMBO Rep. 2024 Jun;25(6):2592-2609. doi: 10.1038/s44319-024-00144-3. Epub 2024 Apr 26. EMBO Rep. 2024. PMID: 38671295 Free PMC article.
• A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.
  Dwivedi AK, Gornalusse GG, Siegel DA, Barbehenn A, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Reppetti J, Vo PM, Levy CN, Roychoudhury P, Jerome KR, Hladik F, Henrich TJ, Deeks SG, Lee SA. Dwivedi AK, et al. PLoS Pathog. 2023 Nov 29;19(11):e1011114. doi: 10.1371/journal.ppat.1011114. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 38019897 Free PMC article.
• Development trends of immune activation during HIV infection in recent three decades: a bibliometric analysis based on CiteSpace.
  Gong K, Lai Y. Gong K, et al. Arch Microbiol. 2023 Jul 11;205(8):283. doi: 10.1007/s00203-023-03624-7. Arch Microbiol. 2023. PMID: 37432538

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)